Your session is about to expire
← Back to Search
Y-Balance Test for Predicting Concussion Risk
Study Summary
This trial is testing whether the YBT-LQ is predictive of concussion in high school athletes, and whether visual perturbations have an effect on the Y-balance and its injury prevention capability.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had seizures in the past.
- Group 1: Standard Y Balance
- Group 2: Y Balance Plus Stroboscopic Glasses
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this experimental protocol welcome elderly enrollees?
"This trial has established 11 as the minimum age for participation and 19 as the maximum."
What is the participant limit for this experiment?
"Affirmative. Information on clinicaltrials.gov clearly states that the trial was initially posted on May 4th 2022 and is presently looking to enrol 1000 participants from 2 different locations."
What criteria must potential participants fulfill to be included in this experimentation?
"Eligibility for this clinical trial necessitates that potential participants have a concussion, are between the ages of 11 and 19, and should be among the 1000 applicants being recruited."
Are there any vacant spots available in this clinical trial currently?
"Data hosted on clinicaltrials.gov affirms that this medical experiment is searching for participants. It was initially posted on May 4th 2022, and it underwent its most recent modifications on April 18th 2022."
Share this study with friends
Copy Link
Messenger